<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Nat Sci Biol Med</journal-id><journal-id journal-id-type="iso-abbrev">J Nat Sci Biol Med</journal-id><journal-id journal-id-type="publisher-id">JNSBM</journal-id><journal-title-group><journal-title>Journal of Natural Science, Biology, and Medicine</journal-title></journal-title-group><issn pub-type="ppub">0976-9668</issn><issn pub-type="epub">2229-7707</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27003964</article-id><article-id pub-id-type="pmc">4780161</article-id><article-id pub-id-type="publisher-id">JNSBM-7-22</article-id><article-id pub-id-type="doi">10.4103/0976-9668.175020</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>High prevalence of multidrug-resistance uropathogenic <italic>Escherichia coli</italic> strains, Isfahan, Iran</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dehbanipour</surname><given-names>Razieh</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Rastaghi</surname><given-names>Sedighe</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Sedighi</surname><given-names>Mansour</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Maleki</surname><given-names>Nafiseh</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Faghri</surname><given-names>Jamshid</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><italic>Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran</italic></aff><aff id="aff2"><label>1</label><italic>Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Tehran, Iran</italic></aff><aff id="aff3"><label>2</label><italic>Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</italic></aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold><italic> Dr. Jamshid Faghri, Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. E-mail: <email xlink:href="Faghri@med.mui.ac.ir">Faghri@med.mui.ac.ir</email></italic></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Jun</season><year>2016</year></pub-date><volume>7</volume><issue>1</issue><fpage>22</fpage><lpage>26</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2016 Journal of Natural Science, Biology and Medicine</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background and Objectives:</title><p>Urinary tract infection (UTI) is one of the most frequent infectious diseases and can occur in all age groups. <italic>Escherichia coli</italic> is the main cause of this infection. Multiple resistances to antimicrobial agents are increasing quickly in <italic>E. coli</italic> isolates and may complicate therapeutic strategies for UTI. The aim of this study was to determine the antibiotic resistance pattern and the multidrug-resistance (MDR) phenotypes in uropathogenic <italic>E. coli</italic> (UPEC).</p></sec><sec id="st2"><title>Materials and Methods:</title><p>A total of 135 UPEC isolates were collected from both outpatients (91 isolates) and inpatients (44 isolates) between September, 2012 and February, 2013. In order to determine the MDR among UPEC isolates, we have tested 15 antimicrobial agents and antibiotic susceptibility was done by Kirby-Bauer disk diffusion method.</p></sec><sec id="st3"><title>Results:</title><p>The percentage of MDR isolates (resistant to at least three drug classes such as aminoglycosides, fluoroquinolones, penicillins, cephalosporins, or carbapenems) was 68% in the inpatients and 61% in the outpatients. Antibiotic resistance to ampicillin, ceftazidim, nalidixic acid, and trimethoprim/sulfamethoxazole were higher than 50%. Amikacin, nitrofurantoin, and gentamicin showed markedly greater activity (89.1%, 85.9%, and 82.4% sensitivity, respectively) than other antimicrobial agents. Resistance to meropenem did show either in outpatients or in inpatients.</p></sec><sec id="st4"><title>Interpretation and Conclusions:</title><p>The high prevalence of drug resistance among UTI patients calls for continuous monitoring of the incidence of drug resistance for appropriate empiric selection of antibiotic therapy. Empirical treatment of UTIs should be relied on susceptibility patterns from local studies.</p></sec></abstract><kwd-group><kwd>Antimicrobial resistance</kwd><kwd><italic>Escherichia coli</italic></kwd><kwd>multidrug resistance</kwd><kwd>urinary tract infections</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Urinary tract infections (UTIs) are the most common infections and are mostly caused by Gram-negative bacteria.[<xref rid="ref1" ref-type="bibr">1</xref>] Almost 150 million cases of UTIs per year were reported worldwide.[<xref rid="ref2" ref-type="bibr">2</xref>] According to an estimation, almost 40-50% of women experience UTIs once in lifetime.[<xref rid="ref3" ref-type="bibr">3</xref>] Recurrent UTI occurs in adult women and results in high healthcare costs.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>] Based on the surveys, UTI is an independent risk factor for renal cell carcinoma and bladder cancer.[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] According to the studies, uropathogenic <italic>Escherichia coli</italic> (UPEC) is the most common cause of UTIs.[<xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>] UPEC isolates possess multiple virulence factors that promote colonization of the bacteria and infection in the urinary tract such as fimbrial, adhesins, afimbrialadhesin, toxins, siderophores, and capsular polysaccharide.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] The clinical experiences have shown a high rate of antibiotic resistance among uropathogens.[<xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref>] Excessive use of antibiotics is the most important factor in the rise of multidrug resistance (MDR) in UPEC isolates.[<xref rid="ref16" ref-type="bibr">16</xref>] Antibiotic resistance is a serious public health emergency leading to increased mortality and morbidity.[<xref rid="ref17" ref-type="bibr">17</xref>] According to the European Centre for Disease Prevention and Control in 2007, antibiotic resistance caused about 25,000 deaths annually which was equal to about half the number of deaths in a road accident in Europe.[<xref rid="ref18" ref-type="bibr">18</xref>] Due to the risk of kidney damage and complications, early diagnosis and treatment of disease is important.[<xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref20" ref-type="bibr">20</xref>] Since UTI cause several complex symptoms, physicians begin empirical antibiotic treatment before getting the culture results because urine culture and antibiogram results take about 4 days to be prepared.[<xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref23" ref-type="bibr">23</xref>] According to reports from the USA, Japan, China, India, Saudi Arabia, Brazil, and Nepal, the prevalence of MDR <italic>E. coli</italic> causing UTIs is increasing.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref24" ref-type="bibr">24</xref><xref rid="ref25" ref-type="bibr">25</xref><xref rid="ref26" ref-type="bibr">26</xref><xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref><xref rid="ref29" ref-type="bibr">29</xref>] The knowledge of the main bacteria usually involved in the UTIs and their antimicrobial susceptibility are necessary for appropriate empirical therapy and prevention of the emergence of antibiotic resistance. Since these data are constantly changing and may vary from hospital to hospital, each institution should determine these information and update them regularly.[<xref rid="ref30" ref-type="bibr">30</xref><xref rid="ref31" ref-type="bibr">31</xref>] The present study aimed to define the current occurrence and phenotypes of MDR <italic>E. coli</italic> among UTI isolates from a university medical center, Alzahra Hospital, Isfahan, Iran.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><sec id="sec2-1"><title>Bacterial isolates</title><p>A total of 135 strains of <italic>E. coli</italic> causing UTIs were isolated from both outpatients (91 isolates) and inpatients (44 isolates) from Alzahra Hospital (Isfahan, Iran). The isolates were collected between September, 2012 and February, 2013. Samples were isolated from the urine. Diagnosis of <italic>E. coli</italic> isolates has been done according to Bailey and Scott's diagnostic microbiological methods.[<xref rid="ref32" ref-type="bibr">32</xref>] The samples were cultured on nutrient agar, MacConkey agar, blood agar, and eosin-methylene blue agar (purchased from Himedia Company). The plates were incubated at 35&#x000b0;C for 24 h and the pure isolates characterized and identified according to Gram-stains and biochemical tests such as catalase, oxidative, citrate utilization, indole production, methyl red-Voges Proskauer, triple iron sugar utilization, and urea test and as described in standard bacteriological methods.[<xref rid="ref32" ref-type="bibr">32</xref>] Quality control was tested by <italic>E. coli</italic> ATCC25922.</p></sec><sec id="sec2-2"><title>Antibiotic susceptibility test</title><p>Bacterial susceptibility to antimicrobial agents was determined by using disk diffusion method as recommended by the Clinical and Laboratory Standards Institute guidelines.[<xref rid="ref33" ref-type="bibr">33</xref>] The antibiotic disks used in this study were ciprofloxacin (CIP) (5 &#x003bc;g), norfloxacin (10 &#x003bc;g), ofloxacin (OFX) (5 &#x003bc;g), nalidixic acid (NAL) (30 &#x003bc;g), amikacin (30 &#x003bc;g), ampicillin (AMP) (10 &#x003bc;g), cefotaxime (CTX) (30 &#x003bc;g), gentamicin (GEN) (10 &#x003bc;g), nitrofurantoin (NOR) (300 &#x003bc;g), trimethoprim/sulfamethoxazole (SXT) (1.75/23.75 &#x003bc;g), cefoxitin (30 &#x003bc;g), meropenem (10 &#x003bc;g), cefepime (FEP) (30 &#x003bc;g), ceftazidime (30 &#x003bc;g), and cephalothin (30 &#x003bc;g).</p><p><italic>E. coli</italic> ATCC25922 was used as a quality control strain. Then the data were entered into Whonet 5.6 (WHO, Geneva, Switzerland) software. An isolate was considered MDR if it was resistant to at least three of the antimicrobial classes such as aminoglycosides, fluoroquinolones, penicillins, cephalosporins, or carbapenems.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>The age distribution was determined based on the decade, and different prevalence patterns were observed in each age range as described in <xref ref-type="table" rid="T1">Table 1</xref>. In total, 68% of the participants were female, and 14% of the samples belong to children.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Age and gender distribution of patients diagnosed with UTI</p></caption><graphic xlink:href="JNSBM-7-22-g001"/></table-wrap><p>The resistance rates of UPEC isolates to antimicrobial agents in both outpatients and inpatients are shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. Antibiotic resistance to AMP, ceftazidim, NAL, and SXT were higher than 50%. The rates of resistance to AMP, SXT, ceftazidim, CTX, and FEP in outpatients were higher than in inpatients. Resistance to meropenem did show neither in outpatients nor in inpatients. Amikacin, NIT, and GEN showed markedly greater activity (89.1%, 85.9%, and 82.4% sensitivity, respectively) than other antimicrobial agents.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Percentages of antibiotic resistance in <italic>Escherichia coli</italic> isolated from outpatients and inpatients</p></caption><graphic xlink:href="JNSBM-7-22-g002"/></fig><p>Antimicrobial susceptibility test showed that the rate of MDR isolates was 68% in inpatients and 61% in outpatients. The isolates were divided into seven groups according to their resistance patterns [<xref ref-type="table" rid="T2">Table 2</xref>]. The most common MDR phenotypes are shown in <xref ref-type="table" rid="T3">Table 3</xref>. The prevalent pattern among total UPEC isolates was CIP, OFX, NOR, NAL, CTX, AMP, FEP, SXT; and it was only among outpatients.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Resistance pattern of the <italic>Escherichia coli</italic> strains</p></caption><graphic xlink:href="JNSBM-7-22-g003"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>The most common antimicrobial resistance phenotypes showing MDR among <italic>Escherichia coli</italic> isolates</p></caption><graphic xlink:href="JNSBM-7-22-g004"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>MDR in UPEC causing UTIs is an emerging and serious public health problem and results in treatment failure. This study provides current information about the antimicrobial resistance pattern in <italic>E. coli</italic> isolates from patients&#x02019; urine samples in the Alzahra Hospital, Isfahan, Iran. Based on the results of the present study, there is a high resistance rate to the commonly used antibiotics in the <italic>E. coli</italic> isolates. We found 63% of the isolates to be resistant to three or more antibiotics. The rates of antibiotic resistance in our study were different from some studies in other countries.[<xref rid="ref18" ref-type="bibr">18</xref><xref rid="ref34" ref-type="bibr">34</xref><xref rid="ref35" ref-type="bibr">35</xref><xref rid="ref36" ref-type="bibr">36</xref><xref rid="ref37" ref-type="bibr">37</xref>] MDR rate was higher in inpatients isolates (68%). A significant high resistance to SXT (61.2%) was found in the present study while many guidelines recommend this drug for UTIs.[<xref rid="ref38" ref-type="bibr">38</xref><xref rid="ref39" ref-type="bibr">39</xref>] In addition, CIP and OFX antibiotics recommended for UTIs, showed high resistance in data from other surveys and European countries according to Annual report of the European Antimicrobial Resistance Surveillance Network in 2012.[<xref rid="ref40" ref-type="bibr">40</xref><xref rid="ref41" ref-type="bibr">41</xref><xref rid="ref42" ref-type="bibr">42</xref>] Excessive use of AMP in the treatment of UTIs, especially in hospitalized patients, gives a possible explanation for the existence of high resistance rate (84.2%) to this antimicrobial agent. The rates of resistance to AMP, SXT and CTX in outpatients were higher than in inpatients while the rates of resistance to fluoroquinolones and NAL in outpatients were lower than in inpatients. According to experts, resistance level &#x0003e;20% is used as a cut-off in guidelines on UTIs, so these antibiotics should not be recommended for the treatment of UTIs.[<xref rid="ref43" ref-type="bibr">43</xref><xref rid="ref44" ref-type="bibr">44</xref>] However, low levels of resistance to amikacin, NIT, and GEN (2.2%, 8.1%, and 16.5%, respectively) and no resistance against meropenem was observed in the present study. Based on our results, the extremely high percentage of isolates showed an MDR phenotype. Some socioeconomic and behavioral factors can contribute to antibiotic resistance such as misuse of antimicrobial agents by hospital physicians or unskilled practitioners and easy access to antibiotics without a prescription.[<xref rid="ref45" ref-type="bibr">45</xref>] These warning resistances to the commonly used antibiotics can affect the therapeutic strategies. The data of the current study cannot be translated to the international level. The successful empirical initial treatment is based on susceptibility and resistance patterns obtaining from local data. Since these susceptibility patterns are constantly changing and may vary in different geographical regions and institutions, regular monitoring of antimicrobial agents resistance seems necessary to formulate standard treatment guidelines for empirical therapy.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>UTI is the most common infectious disease. As bacterial resistance to the common antimicrobial agents has increased considerably among <italic>E. coli</italic> causing UTIs, empirical antibiotic treatment should be reviewed periodically at a regional level.</p></sec><sec id="sec1-6"><title>STUDY LIMITATIONS</title><p>One limitation of this study was the lack of extended-spectrum beta-lactamase-testing to determine the minimum inhibitory concentration of antibiotics and further analysis for a more accurate measure of antibiotic resistance.</p><sec id="sec2-3"><title>Financial support and sponsorship</title><p>This study was funded by the Isfahan University of Medical Sciences.</p></sec><sec id="sec2-4"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank the members of Alzahra Hospital of Isfahan city for their technical assistance and help with the English language version of this paper.</p></ack><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niranjan</surname><given-names>V</given-names></name><name><surname>Malini</surname><given-names>A</given-names></name></person-group><article-title>Antimicrobial resistance pattern in <italic>Escherichia coli</italic> causing urinary tract infection among inpatients</article-title><source>Indian J Med Res</source><year>2014</year><volume>139</volume><fpage>945</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">25109731</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>MP</given-names></name><name><surname>Debata</surname><given-names>NK</given-names></name><name><surname>Padhy</surname><given-names>RN</given-names></name></person-group><article-title>Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian</article-title><source>Asian Pac J Trop Biomed</source><year>2013</year><volume>3</volume><fpage>315</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">23620859</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momtaz</surname><given-names>H</given-names></name><name><surname>Karimian</surname><given-names>A</given-names></name><name><surname>Madani</surname><given-names>M</given-names></name><name><surname>Safarpoor</surname><given-names>Dehkordi F</given-names></name><name><surname>Ranjbar</surname><given-names>R</given-names></name><name><surname>Sarshar</surname><given-names>M</given-names></name><etal/></person-group><article-title>Uropathogenic <italic>Escherichia coli</italic> in Iran: Serogroup distributions, virulence factors and antimicrobial resistance properties</article-title><source>Ann Clin Microbiol Antimicrob</source><year>2013</year><volume>12</volume><fpage>8</fpage><pub-id pub-id-type="pmid">23627669</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flower</surname><given-names>A</given-names></name><name><surname>Bishop</surname><given-names>FL</given-names></name><name><surname>Lewith</surname><given-names>G</given-names></name></person-group><article-title>How women manage recurrent urinary tract infections: An analysis of postings on a popular web forum</article-title><source>BMC Fam Pract</source><year>2014</year><volume>15</volume><fpage>162</fpage><pub-id pub-id-type="pmid">25260870</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickling</surname><given-names>DR</given-names></name><name><surname>Nitti</surname><given-names>VW</given-names></name></person-group><article-title>Management of recurrent urinary tract infections in healthy adult women</article-title><source>Rev Urol</source><year>2013</year><volume>15</volume><fpage>41</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">24082842</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>AS</given-names></name><name><surname>Cerhan</surname><given-names>JR</given-names></name><name><surname>Lynch</surname><given-names>CF</given-names></name><name><surname>Leibovich</surname><given-names>BC</given-names></name><name><surname>Cantor</surname><given-names>KP</given-names></name></person-group><article-title>History of urinary tract infection and risk of renal cell carcinoma</article-title><source>Am J Epidemiol</source><year>2004</year><volume>159</volume><fpage>42</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14693658</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaeffer</surname><given-names>EM</given-names></name></person-group><article-title>Re: Antimicrobial susceptibility of global inpatient urinary tract isolates of <italic>Escherichia coli</italic>: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010</article-title><source>J Urol</source><year>2012</year><volume>187</volume><fpage>1280</fpage><pub-id pub-id-type="pmid">22423919</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Francesco</surname><given-names>MA</given-names></name><name><surname>Ravizzola</surname><given-names>G</given-names></name><name><surname>Peroni</surname><given-names>L</given-names></name><name><surname>Negrini</surname><given-names>R</given-names></name><name><surname>Manca</surname><given-names>N</given-names></name></person-group><article-title>Urinary tract infections in Brescia, Italy: Etiology of uropathogens and antimicrobial resistance of common uropathogens</article-title><source>Med Sci Monit</source><year>2007</year><volume>13</volume><fpage>BR136</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">17534228</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laupland</surname><given-names>KB</given-names></name><name><surname>Ross</surname><given-names>T</given-names></name><name><surname>Pitout</surname><given-names>JD</given-names></name><name><surname>Church</surname><given-names>DL</given-names></name><name><surname>Gregson</surname><given-names>DB</given-names></name></person-group><article-title>Community-onset urinary tract infections: A population-based assessment</article-title><source>Infection</source><year>2007</year><volume>35</volume><fpage>150</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">17565455</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kucheria</surname><given-names>R</given-names></name><name><surname>Dasgupta</surname><given-names>P</given-names></name><name><surname>Sacks</surname><given-names>SH</given-names></name><name><surname>Khan</surname><given-names>MS</given-names></name><name><surname>Sheerin</surname><given-names>NS</given-names></name></person-group><article-title>Urinary tract infections: New insights into a common problem</article-title><source>Postgrad Med J</source><year>2005</year><volume>81</volume><fpage>83</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15701738</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiba</surname><given-names>MR</given-names></name><name><surname>Yano</surname><given-names>T</given-names></name><name><surname>Leite Dda</surname><given-names>S</given-names></name></person-group><article-title>Genotypic characterization of virulence factors in <italic>Escherichia coli</italic> strains from patients with cystitis</article-title><source>Rev Inst Med Trop Sao Paulo</source><year>2008</year><volume>50</volume><fpage>255</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">18949339</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asadi</surname><given-names>S</given-names></name><name><surname>Kargar</surname><given-names>M</given-names></name><name><surname>Solhjoo</surname><given-names>K</given-names></name><name><surname>Najafi</surname><given-names>A</given-names></name><name><surname>Ghorbani-Dalini</surname><given-names>S</given-names></name></person-group><article-title>The association of virulence determinants of uropathogenic <italic>Escherichia coli</italic> with antibiotic resistance</article-title><source>Jundishapur J Microbiol</source><year>2014</year><volume>7</volume><fpage>e9936</fpage><pub-id pub-id-type="pmid">25147722</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltani</surname><given-names>R</given-names></name><name><surname>Ehsanpoor</surname><given-names>M</given-names></name><name><surname>Khorvash</surname><given-names>F</given-names></name><name><surname>Shokri</surname><given-names>D</given-names></name></person-group><article-title>Antimicrobial susceptibility pattern of extended-spectrum &#x003b2;-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital</article-title><source>J Res Pharm Pract</source><year>2014</year><volume>3</volume><fpage>6</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">24991629</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedighi</surname><given-names>M</given-names></name><name><surname>Salehi-Abargouei</surname><given-names>A</given-names></name><name><surname>Oryan</surname><given-names>G</given-names></name><name><surname>Faghri</surname><given-names>J</given-names></name></person-group><article-title>Epidemiology of VIM-1-imipenem resistant <italic>Pseudomonas aeruginosa</italic> in Iran: A systematic review and meta-analysis</article-title><source>J Res Med Sci</source><year>2014</year><volume>19</volume><fpage>899</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">25535506</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baral</surname><given-names>P</given-names></name><name><surname>Neupane</surname><given-names>S</given-names></name><name><surname>Marasini</surname><given-names>BP</given-names></name><name><surname>Ghimire</surname><given-names>KR</given-names></name><name><surname>Lekhak</surname><given-names>B</given-names></name><name><surname>Shrestha</surname><given-names>B</given-names></name></person-group><article-title>High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal</article-title><source>BMC Res Notes</source><year>2012</year><volume>5</volume><fpage>38</fpage><pub-id pub-id-type="pmid">22260454</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>TD</given-names></name><name><surname>McLaughlin</surname><given-names>W</given-names></name><name><surname>Brown</surname><given-names>PD</given-names></name></person-group><article-title>Antimicrobial resistance of <italic>Escherichia coli</italic> isolates from broiler chickens and humans</article-title><source>BMC Vet Res</source><year>2006</year><volume>2</volume><fpage>7</fpage><pub-id pub-id-type="pmid">16460561</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyar</surname><given-names>OJ</given-names></name><name><surname>Hoa</surname><given-names>NQ</given-names></name><name><surname>Trung</surname><given-names>NV</given-names></name><name><surname>Phuc</surname><given-names>HD</given-names></name><name><surname>Larsson</surname><given-names>M</given-names></name><name><surname>Chuc</surname><given-names>NT</given-names></name><etal/></person-group><article-title>High prevalence of antibiotic resistance in commensal <italic>Escherichia coli</italic> among children in rural Vietnam</article-title><source>BMC Infect Dis</source><year>2012</year><volume>12</volume><fpage>92</fpage><pub-id pub-id-type="pmid">22512857</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linhares</surname><given-names>I</given-names></name><name><surname>Raposo</surname><given-names>T</given-names></name><name><surname>Rodrigues</surname><given-names>A</given-names></name><name><surname>Almeida</surname><given-names>A</given-names></name></person-group><article-title>Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: A ten-year surveillance study (2000-2009)</article-title><source>BMC Infect Dis</source><year>2013</year><volume>13</volume><fpage>19</fpage><pub-id pub-id-type="pmid">23327474</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>R</given-names></name><name><surname>Lakhanpaul</surname><given-names>M</given-names></name><name><surname>Verrier-Jones</surname><given-names>K</given-names></name></person-group><article-title>Diagnosis and management of urinary tract infection in children: Summary of NICE guidance</article-title><source>BMJ</source><year>2007</year><volume>335</volume><fpage>395</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17717369</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><article-title>Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: Clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months</article-title><source>Pediatrics</source><year>2011</year><volume>128</volume><fpage>595</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">21873693</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooton</surname><given-names>TM</given-names></name></person-group><article-title>Clinical practice. Uncomplicated urinary tract infection</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><fpage>1028</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">22417256</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>K</given-names></name><name><surname>Hooton</surname><given-names>TM</given-names></name><name><surname>Naber</surname><given-names>KG</given-names></name><name><surname>Wullt</surname><given-names>B</given-names></name><name><surname>Colgan</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>LG</given-names></name><etal/></person-group><article-title>International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases</article-title><source>Clin Infect Dis</source><year>2011</year><volume>52</volume><fpage>e103</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">21292654</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>DS</given-names></name><name><surname>Shieh</surname><given-names>HH</given-names></name><name><surname>Ragazzi</surname><given-names>SL</given-names></name><name><surname>Koch</surname><given-names>VH</given-names></name><name><surname>Martinez</surname><given-names>MB</given-names></name><name><surname>Gilio</surname><given-names>AE</given-names></name></person-group><article-title>Community-acquired urinary tract infection: Age and gender-dependent etiology</article-title><source>J Bras Nefrol</source><year>2013</year><volume>35</volume><fpage>93</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23812565</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahm</surname><given-names>DF</given-names></name><name><surname>Thornsberry</surname><given-names>C</given-names></name><name><surname>Mayfield</surname><given-names>DC</given-names></name><name><surname>Jones</surname><given-names>ME</given-names></name><name><surname>Karlowsky</surname><given-names>JA</given-names></name></person-group><article-title>Multidrug-resistant urinary tract isolates of <italic>Escherichia coli</italic>: Prevalence and patient demographics in the United States in 2000</article-title><source>Antimicrob Agents Chemother</source><year>2001</year><volume>45</volume><fpage>1402</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11302802</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafay</surname><given-names>AM</given-names></name><name><surname>Nsanze</surname><given-names>HN</given-names></name></person-group><article-title>Multi-drug resistance of <italic>Escherichia coli</italic> from the urinary tract</article-title><source>Saudi Med J</source><year>2003</year><volume>24</volume><fpage>261</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12704500</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathai</surname><given-names>E</given-names></name><name><surname>Grape</surname><given-names>M</given-names></name><name><surname>Kronvall</surname><given-names>G</given-names></name></person-group><article-title>Integrons and multidrug resistance among <italic>Escherichia coli</italic> causing community-acquired urinary tract infection in southern India</article-title><source>APMIS</source><year>2004</year><volume>112</volume><fpage>159</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">15153157</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Hayakawa</surname><given-names>S</given-names></name><name><surname>Miyakawa</surname><given-names>S</given-names></name><name><surname>Kusaka</surname><given-names>M</given-names></name><name><surname>Shiroki</surname><given-names>R</given-names></name><name><surname>Hoshinaga</surname><given-names>K</given-names></name></person-group><article-title>Survey of the susceptibility of urinary isolates to antibacterial agents in 2003</article-title><source>J Infect Chemother</source><year>2005</year><volume>11</volume><fpage>44</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15729488</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>PL</given-names></name><name><surname>Wong</surname><given-names>RC</given-names></name><name><surname>Yip</surname><given-names>KS</given-names></name><name><surname>Loke</surname><given-names>SL</given-names></name><name><surname>Leung</surname><given-names>MS</given-names></name><name><surname>Mak</surname><given-names>GC</given-names></name><etal/></person-group><article-title>Antimicrobial resistance in <italic>Escherichia coli</italic> outpatient urinary isolates from women: Emerging multidrug resistance phenotypes</article-title><source>Diagn Microbiol Infect Dis</source><year>2007</year><volume>59</volume><fpage>439</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">17888610</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumari</surname><given-names>N</given-names></name><name><surname>Ghimire</surname><given-names>G</given-names></name><name><surname>Magar</surname><given-names>JK</given-names></name><name><surname>Mohapatra</surname><given-names>TM</given-names></name><name><surname>Rai</surname><given-names>A</given-names></name></person-group><article-title>Antibiogram pattern of isolates from UTI cases in Eastern part of Nepal</article-title><source>Nepal Med Coll J</source><year>2005</year><volume>7</volume><fpage>116</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16519077</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagenlehner</surname><given-names>F</given-names></name><name><surname>Naber</surname><given-names>K</given-names></name></person-group><article-title>Antibiotics and resistance of uropathogens</article-title><source>EAU Update Ser</source><year>2004</year><volume>2</volume><fpage>125</fpage><lpage>35</lpage></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias Neto</surname><given-names>JA</given-names></name><name><surname>Martins</surname><given-names>AC</given-names></name><name><surname>Silva</surname><given-names>LD</given-names></name><name><surname>Tiraboschi</surname><given-names>RB</given-names></name><name><surname>Domingos</surname><given-names>AL</given-names></name><name><surname>Cologna</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Community acquired urinary tract infection: Etiology and bacterial susceptibility</article-title><source>Acta Cir Bras</source><year>2003</year><volume>18</volume><fpage>33</fpage><lpage>6</lpage></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tille</surname><given-names>P</given-names></name></person-group><article-title>Bailey &#x00026; Scott's Diagnostic Microbiology</article-title><year>2013</year><publisher-loc>China</publisher-loc><publisher-name>Elsevier Health Sciences</publisher-name></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cockerill</surname><given-names>FR</given-names></name><name><surname>Clinical</surname></name><name><surname>Institute</surname><given-names>LS</given-names></name></person-group><article-title>Performance Standards for Antimicrobial Disk Susceptibility Testing: Approved Standard</article-title><year>2012</year><publisher-loc>Wayne, USA</publisher-loc><publisher-name>National Committee for Clinical Laboratory Standards</publisher-name></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koningstein</surname><given-names>M</given-names></name><name><surname>van der Bij</surname><given-names>AK</given-names></name><name><surname>de Kraker</surname><given-names>ME</given-names></name><name><surname>Monen</surname><given-names>JC</given-names></name><name><surname>Muilwijk</surname><given-names>J</given-names></name><name><surname>de Greeff</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e86634</fpage><pub-id pub-id-type="pmid">24489755</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mowla</surname><given-names>R</given-names></name><name><surname>Imam</surname><given-names>KM</given-names></name><name><surname>Asaduzzaman</surname><given-names>M</given-names></name><name><surname>Nasrin</surname><given-names>N</given-names></name><name><surname>Raihan</surname><given-names>SZ</given-names></name><name><surname>Chowdhury</surname><given-names>AK</given-names></name></person-group><article-title>Emergence of multidrug resistant extended-spectrum &#x003b2;-lactamase producing <italic>Eshcherichia coli</italic> associated with urinary tract infections in Bangladesh</article-title><source>J Basic Clin Pharm</source><year>2011</year><volume>3</volume><fpage>225</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">24826028</pub-id></element-citation></ref><ref id="ref36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jafri</surname><given-names>SA</given-names></name><name><surname>Qasim</surname><given-names>M</given-names></name><name><surname>Masoud</surname><given-names>MS</given-names></name><name><surname>Rahman</surname><given-names>MU</given-names></name><name><surname>Izhar</surname><given-names>M</given-names></name><name><surname>Kazmi</surname><given-names>S</given-names></name></person-group><article-title>Antibiotic resistance of <italic>E. coli</italic> isolates from urine samples of Urinary Tract Infection (UTI) patients in Pakistan</article-title><source>Bioinformation</source><year>2014</year><volume>10</volume><fpage>419</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">25187681</pub-id></element-citation></ref><ref id="ref37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname><given-names>J</given-names></name><name><surname>Acharya</surname><given-names>NS</given-names></name><name><surname>Buddhapriya</surname><given-names>D</given-names></name><name><surname>Parija</surname><given-names>SC</given-names></name></person-group><article-title>Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant <italic>Escherichia coli</italic></article-title><source>Indian J Med Res</source><year>2012</year><volume>136</volume><fpage>842</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">23287133</pub-id></element-citation></ref><ref id="ref38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuorela</surname><given-names>M</given-names></name><name><surname>Kouri</surname><given-names>T</given-names></name><name><surname>Laato</surname><given-names>M</given-names></name><name><surname>Lipponen</surname><given-names>P</given-names></name><name><surname>Sammalkorpi</surname><given-names>K</given-names></name><name><surname>Uhari</surname><given-names>M</given-names></name><etal/></person-group><article-title>Update on current care guidelines: Urinary tract infections</article-title><source>Duodecim</source><year>2011</year><volume>127</volume><fpage>2334</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">22204148</pub-id></element-citation></ref><ref id="ref39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Pinxteren</surname><given-names>B</given-names></name><name><surname>van Vliet</surname><given-names>SM</given-names></name><name><surname>Wiersma</surname><given-names>TJ</given-names></name><name><surname>Goudswaard</surname><given-names>AN</given-names></name></person-group><article-title>Nederlands Huisartsen Genootschap. Summary of the practice guideline &#x02018;Urinary-tract infections&#x02019; (second revision) from the Dutch College of General Practitioners</article-title><source>Ned Tijdschr Geneeskd</source><year>2006</year><volume>150</volume><fpage>718</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">16623344</pub-id></element-citation></ref><ref id="ref40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Nayak</surname><given-names>S</given-names></name><name><surname>Bhattacharyya</surname><given-names>I</given-names></name><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Mandal</surname><given-names>AK</given-names></name><name><surname>Chakraborty</surname><given-names>S</given-names></name><etal/></person-group><article-title>Understanding the patterns of antibiotic susceptibility of bacteria causing urinary tract infection in West Bengal, India</article-title><source>Front Microbiol</source><year>2014</year><volume>5</volume><fpage>463</fpage><pub-id pub-id-type="pmid">25278932</pub-id></element-citation></ref><ref id="ref41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmiemann</surname><given-names>G</given-names></name><name><surname>G&#x000e1;gyor</surname><given-names>I</given-names></name><name><surname>Hummers-Pradier</surname><given-names>E</given-names></name><name><surname>Bleidorn</surname><given-names>J</given-names></name></person-group><article-title>Resistance profiles of urinary tract infections in general practice: An observational study</article-title><source>BMC Urol</source><year>2012</year><volume>12</volume><fpage>33</fpage><pub-id pub-id-type="pmid">23171154</pub-id></element-citation></ref><ref id="ref42"><label>42</label><element-citation publication-type="book"><article-title>European Centre for Disease Prevention and Control. Antimicrobial Resistance Surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)</article-title><year>2013</year><publisher-loc>Stockholm</publisher-loc><publisher-name>ECDC</publisher-name></element-citation></ref><ref id="ref43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabe</surname><given-names>M</given-names></name><name><surname>Bishop</surname><given-names>M</given-names></name><name><surname>Bjerklund-Johansen</surname><given-names>T</given-names></name><name><surname>Botto</surname><given-names>H</given-names></name><name><surname>&#x000c7;ek</surname><given-names>M</given-names></name><name><surname>Lobel</surname><given-names>B</given-names></name><etal/></person-group><article-title>Management of urinary and male genital tract infections</article-title><source>Update</source><year>2008</year><volume>5</volume><fpage>47</fpage><lpage>60</lpage></element-citation></ref><ref id="ref44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagenlehner</surname><given-names>FM</given-names></name><name><surname>Schmiemann</surname><given-names>G</given-names></name><name><surname>Hoyme</surname><given-names>U</given-names></name><name><surname>F&#x000fc;nfst&#x000fc;ck</surname><given-names>R</given-names></name><name><surname>Hummers-Pradier</surname><given-names>E</given-names></name><name><surname>Kaase</surname><given-names>M</given-names></name><etal/></person-group><article-title>National S3 guideline on uncomplicated urinary tract infection: Recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients</article-title><source>Urologe A</source><year>2011</year><volume>50</volume><fpage>153</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">21312083</pub-id></element-citation></ref><ref id="ref45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okeke</surname><given-names>IN</given-names></name><name><surname>Lamikanra</surname><given-names>A</given-names></name><name><surname>Edelman</surname><given-names>R</given-names></name></person-group><article-title>Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries</article-title><source>Emerg Infect Dis</source><year>1999</year><volume>5</volume><fpage>18</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">10081668</pub-id></element-citation></ref></ref-list></back></article>